Page last updated: 2024-08-23

paroxetine and Innate Inflammatory Response

paroxetine has been researched along with Innate Inflammatory Response in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's9 (69.23)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Bairlein, M; Bräuer, N; Dahllöf, H; Hillig, RC; Klint, J; Laux-Biehlmann, A; Mesch, S; Neagoe, I; Nubbemeyer, R; Puetter, V; Schulz, S; Steinmeyer, A; Ter Laak, A; Werner, S; Zollner, TM1
Chen, H; Cui, Z; Gao, Z; Hong, J; Li, X; Ma, Y; Ning, L; Tong, T; Wang, X; Wang, Z; Xuan, B; Yan, Y1
Gu, J; Ji, G; Song, F; Wu, L; Wu, W; Zhu, Y1
Nasrallah, HA; Sagarwala, R1
He, JH; Hou, NN; Huang, CP; Ji, SY; Zhang, CN; Zhang, HQ; Zhang, X; Zhu, JH; Zhu, LB1
Hsu, BG; Hu, TM; Lee, RP; Lin, NT; Subeq, YM; Yang, FL1
Fujimori, K; Sato, K; Sekino, Y; Shigemoto-Mogami, Y; Suzuki, T; Takaki, J1
Assies, J; Koeter, MWJ; Mocking, RJT; Nap, TS; Ruhé, HG; Schene, AH; Vaz, FM; Westerink, AM1
Colado, MI; Izco, M; Llopis, N; O'Shea, E; Orio, L; Torres, E1
Chung, YC; Jin, BK; Kim, SR1
Hannestad, J1
Jun, IG; Kim, SH; Lee, BS; Park, JY1
Ikeda, S; Jiang, J; Kuhara, T; Ogawa, H; Suto, H; Ueki, R; Zheng, Y1

Reviews

1 review(s) available for paroxetine and Innate Inflammatory Response

ArticleYear
Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2019, Volume: 31, Issue:4

    Topics: Biomarkers; Humans; Hydrocortisone; Inflammation; Interleukin-1beta; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic

2019

Other Studies

12 other study(ies) available for paroxetine and Innate Inflammatory Response

ArticleYear
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor
    Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24

    Topics: Acetamides; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Drug Discovery; Enzyme Induction; Female; Gene Expression Regulation; Humans; Inflammation; Ligands; Male; Mice; Mice, Inbred C57BL; Pain; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2X4

2019
Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Anti-Inflammatory Agents; Antidepressive Agents; Depression; Humans; Inflammation; Inflammatory Bowel Diseases; Paroxetine; Tumor Necrosis Factor Inhibitors

2023
Paroxetine induced larva zebrafish cardiotoxicity through inflammation response.
    Ecotoxicology and environmental safety, 2023, Jul-15, Volume: 260

    Topics: Animals; Cardiotoxicity; Embryo, Nonmammalian; Inflammation; Larva; Paroxetine; T-Box Domain Proteins; Water Pollutants, Chemical; Zebrafish; Zebrafish Proteins

2023
Paroxetine suppresses reactive microglia-mediated but not lipopolysaccharide-induced inflammatory responses in primary astrocytes.
    Journal of neuroinflammation, 2020, Feb-05, Volume: 17, Issue:1

    Topics: Animals; Astrocytes; Cell Line; Humans; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice; Microglia; Nitric Oxide Synthase Type II; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha

2020
The use of a selective serotonin reuptake inhibitor decreases heavy alcohol exposure-induced inflammatory response and tissue damage in rats.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:10

    Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Enzymes; Ethanol; Inflammation; Interleukin-6; L-Lactate Dehydrogenase; Liver; Lung; Male; Pancreas; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha

2013
Paroxetine prevented the down-regulation of astrocytic L-Glu transporters in neuroinflammation.
    Journal of pharmacological sciences, 2015, Volume: 127, Issue:1

    Topics: Amino Acid Transport System X-AG; Antidepressive Agents; Astrocytes; Cells, Cultured; Down-Regulation; Glutamic Acid; Humans; Inflammation; Lipopolysaccharides; Microglia; Neurons; Paroxetine

2015
Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
    Psychoneuroendocrinology, 2017, Volume: 79

    Topics: Adult; Amygdala; Antidepressive Agents; C-Reactive Protein; Depressive Disorder, Major; Fatty Acids; Female; Humans; Inflammation; Lipid Metabolism; Magnetic Resonance Imaging; Male; Middle Aged; Paroxetine; Prospective Studies

2017
A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.
    Neurotoxicity research, 2010, Volume: 18, Issue:2

    Topics: Animals; Drug Administration Schedule; Fever; Frontal Lobe; Hypothalamus; Inflammation; Interleukin-1beta; Male; Microglia; Minocycline; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; NF-kappa B; Paroxetine; Radioligand Assay; Rats; Rats, Inbred Strains; Serotonin; Serotonin Plasma Membrane Transport Proteins

2010
Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
    Journal of immunology (Baltimore, Md. : 1950), 2010, Jul-15, Volume: 185, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antidepressive Agents, Second-Generation; Blotting, Western; Brain; Dopamine; Enzyme Activation; Immunohistochemistry; Inflammation; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Motor Activity; NADPH Oxidases; Neurons; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease, Secondary; Paroxetine; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Tumor Necrosis Factor-alpha

2010
Comment on "Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease".
    Journal of immunology (Baltimore, Md. : 1950), 2010, Nov-01, Volume: 185, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Brain; Citalopram; Encephalitis; Humans; Inflammation; Lipopolysaccharides; Mice; Nerve Degeneration; Neurons; Oxidative Stress; Parkinsonian Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors

2010
Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain.
    Journal of Korean medical science, 2012, Volume: 27, Issue:4

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Citalopram; Disease Models, Animal; Hyperalgesia; Inflammation; Injections, Spinal; Male; Morphine; Pain; Pain Measurement; Pain Threshold; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Temperature; Time Factors

2012
Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice.
    Journal of dermatological science, 2007, Volume: 47, Issue:3

    Topics: Administration, Oral; Animals; Antipruritics; Dermatitis, Atopic; Disease Models, Animal; Female; Inflammation; Mice; Mice, Transgenic; Paroxetine; Selective Serotonin Reuptake Inhibitors; Skin; Time Factors

2007